Characteristics Of SARS-CoV-2 And COVID-19 - PubMed

Trang chủ » Hu Et Al. 2020 » Characteristics Of SARS-CoV-2 And COVID-19 - PubMed

Có thể bạn quan tâm

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content Dot gov

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation pubmed logo Search: Search Advanced Clipboard User Guide Save Email Send to
  • Clipboard
  • My Bibliography
  • Collections
  • Citation manager
Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Subject: 1 selected item: 33024307 - PubMed To: From: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

  • Create a new collection
  • Add to an existing collection
Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

  • My Bibliography
Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons
  • Yes
  • No
Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

full text provider logo Nature Publishing Group Free PMC article Full text links

Actions

CiteCollectionsAdd to Collections
  • Create a new collection
  • Add to an existing collection
Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel Display options Display options Format AbstractPubMedPMID

Share

  • Permalink Copy

Page navigation

  • Title & authors
  • Erratum in
  • Abstract
  • Conflict of interest statement
  • Figures
  • Similar articles
  • Cited by
  • References
  • Publication types
  • MeSH terms
  • Related information
  • LinkOut - more resources
Title & authors Erratum in Abstract Conflict of interest statement Figures Similar articles Cited by References Publication types MeSH terms Related information LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Erratum in

  • Author Correction: Characteristics of SARS-CoV-2 and COVID-19. Hu B, Guo H, Zhou P, Shi ZL. Hu B, et al. Nat Rev Microbiol. 2022 May;20(5):315. doi: 10.1038/s41579-022-00711-2. Nat Rev Microbiol. 2022. PMID: 35197601 Free PMC article. No abstract available.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named 'coronavirus disease 2019' (COVID-19), which threatens human health and public safety. In this Review, we describe the basic virology of SARS-CoV-2, including genomic characteristics and receptor use, highlighting its key difference from previously known coronaviruses. We summarize current knowledge of clinical, epidemiological and pathological features of COVID-19, as well as recent progress in animal models and antiviral treatment approaches for SARS-CoV-2 infection. We also discuss the potential wildlife hosts and zoonotic origin of this emerging virus in detail.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1

Fig. 1. Timeline of the key events…

Fig. 1. Timeline of the key events of the COVID-19 outbreak.

The first recorded cases…

Fig. 1. Timeline of the key events of the COVID-19 outbreak. The first recorded cases were reported in December 2019 in Wuhan, China. Over the course of the following 10 months, more than 30 million cases have been confirmed worldwide. COVID-19, coronavirus disease 2019; ICTV, International Committee on Taxonomy of Viruses; PHEIC, public health emergency of international concern; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization.
Fig. 2

Fig. 2. Phylogenetic tree of the full-length…

Fig. 2. Phylogenetic tree of the full-length genome sequences of SARS-CoV-2, SARSr-CoVs and other betacoronaviruses.

Fig. 2. Phylogenetic tree of the full-length genome sequences of SARS-CoV-2, SARSr-CoVs and other betacoronaviruses. The construction was performed by the neighbour joining method with use of the program MEGA6 with bootstrap values being calculated from 1,000 trees. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clusters with closely related viruses in bats and pangolins and together with SARS-CoV and bat SARS-related coronaviruses (SARSr-CoVs) forms the sarbecoviruses. The sequences were downloaded from the GISAID database and GenBank. MERS-CoV, Middle East respiratory syndrome coronavirus.
Fig. 3

Fig. 3. Key differences in the spike…

Fig. 3. Key differences in the spike protein of SARS-CoV-2 and related coronaviruses.

a |…
Fig. 3. Key differences in the spike protein of SARS-CoV-2 and related coronaviruses. a | Schematic diagram of the spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2. The residue numbers of each region correspond to their positions in the S proteins of SARS-CoV and SARS-CoV-2. The dark blue blocks represent insertions in the S protein. The insertions at amino acids 675–691 of the SARS-CoV-2 S protein are shown in an enlargement at the bottom right and aligned with those of other coronaviruses in the same region. b | Alignment of the receptor-binding domain (RBD) in SARS-CoV-2, SARS-CoV BJ01, RaTG13, pangolin coronavirus reported from Guangdong, China (GD pangolin), pangolin coronavirus reported from Guangxi, China (GX pangolin) and bat SARS-related coronavirus (SARSr-CoV) WIV1. The receptor-binding motif (RBM) is shown in purple, and the five key residues that contact angiotensin-converting enzyme 2 (ACE2) directly are highlighted in green. c | Five critical residues in the RBD of SARS-CoV-2 and other viruses. d | Comparison of the structure of SARS-CoV-2 and SARS-CoV RBD complexed with human ACE2 (hACE2); SARS-CoV-2 RBM in purple, SARS-CoV RBM in yellow and hACE2 in green). Five critical residues that are involved in the RBM–ACE2 binding are shown. The Protein Data Bank codes are 2AJF for SARS-CoV RBD–hACE2 and 6VW1 for SARS-CoV-2 RBD–hACE2. The GenBank entries are AY278488 for SARS-CoV BJ01, MN996532 for the bat SARSr-CoV RaTG13, MT121216 and MT072864 for the GD pangolin and GX pangolin coronaviruses, respectively, and KF367457 for the bat SARSr-CoV WIV1. CP, cytoplasmic domain; FP, fusion peptide; HR1, heptad repeat 1; HR2, heptad repeat 2; NTD, N-terminal domain; SP, signal peptide; TM, transmembrane domain. Parts a and b adapted from ref., Springer Nature Limited.
Fig. 4

Fig. 4. Clinical features of COVID-19.

Typical…

Fig. 4. Clinical features of COVID-19.

Typical symptoms of coronavirus disease 2019 (COVID-19) are fever,…

Fig. 4. Clinical features of COVID-19. Typical symptoms of coronavirus disease 2019 (COVID-19) are fever, dry cough and fatigue and in severer cases dyspnea. Many infections, in particular in children and young adults, are asymptomatic, whereas older people and/or people with co-morbidities are at higher risk of severe disease, respiratory failure and death. The incubation period is ~5 days, severe disease usually develops ~8 days after symptom onset and critical disease and death occur at ~16 days. ARDS, acute respiratory distress syndrome; ICU, intensive care unit.
Fig. 5

Fig. 5. SARS-CoV-2 replication and potential therapeutic…

Fig. 5. SARS-CoV-2 replication and potential therapeutic targets.

Potential antivirals target the different steps of…

Fig. 5. SARS-CoV-2 replication and potential therapeutic targets. Potential antivirals target the different steps of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication, ranging from receptor binding, entry and fusion to replication. Furthermore, immunoglobulin-based and immunomodulatory drugs are potential therapeutics as well. Note that robust data on clinical efficacy are lacking for most of these treatments so far. 3CLpro, 3C-like protease; ACE2, angiotensin-converting enzyme 2; CR3022, a SARS-CoV-specific human monoclonal antibody; E, envelope protein; EK1C4, lipopeptide derived from EK1 which is a pan-coronavirus fusion inhibitor targeting the HR1 domain of the spike protein; ER, endoplasmic reticulum; gRNA, genomic RNA; HR2P, heptad repeat 2-derived peptides of SARS-CoV-2 spike protein; IL-6, interleukin-6; ISG, interferon-stimulated gene; M, membrane protein; RdRp, RNA-dependent RNA polymerases; sgRNA, subgenomic RNA; S, spike protein; TMPRSS2, transmembrane protease serine protease 2.
See this image and copyright information in PMC

Similar articles

  • Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review. Tabibzadeh A, Esghaei M, Soltani S, Yousefi P, Taherizadeh M, Safarnezhad Tameshkel F, Golahdooz M, Panahi M, Ajdarkosh H, Zamani F, Karbalaie Niya MH. Tabibzadeh A, et al. Vet Med Sci. 2021 Mar;7(2):559-571. doi: 10.1002/vms3.394. Epub 2020 Nov 18. Vet Med Sci. 2021. PMID: 33210477 Free PMC article. Review.
  • In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data. Obajuluwa AO, Okiki PA, Obajuluwa TM, Afolabi OB. Obajuluwa AO, et al. Pan Afr Med J. 2020 Nov 30;37:285. doi: 10.11604/pamj.2020.37.285.24663. eCollection 2020. Pan Afr Med J. 2020. PMID: 33654512 Free PMC article.
  • A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective. Na W, Moon H, Song D. Na W, et al. J Microbiol. 2021 Mar;59(3):332-340. doi: 10.1007/s12275-021-0660-4. Epub 2021 Feb 23. J Microbiol. 2021. PMID: 33624270 Free PMC article. Review.
  • Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases. Fung TS, Liu DX. Fung TS, et al. Annu Rev Microbiol. 2021 Oct 8;75:19-47. doi: 10.1146/annurev-micro-110520-023212. Epub 2021 Jan 25. Annu Rev Microbiol. 2021. PMID: 33492978
  • Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2. Goraichuk IV, Arefiev V, Stegniy BT, Gerilovych AP. Goraichuk IV, et al. Virus Res. 2021 Sep;302:198473. doi: 10.1016/j.virusres.2021.198473. Epub 2021 Jun 9. Virus Res. 2021. PMID: 34118360 Free PMC article. Review.
See all similar articles

Cited by

  • Non-RBD peptides of SARS-CoV-2 spike protein exhibit immunodominance as they elicit both innate and adaptive immune responses. Rathore D, Chauhan P, Bonagiri A, Gandhi L, Maisnam D, Kumar R, Row AT, Kesavulu MM, Venkataramana M. Rathore D, et al. Heliyon. 2024 Oct 29;10(21):e39941. doi: 10.1016/j.heliyon.2024.e39941. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39568852 Free PMC article.
  • COVID-19 vaccines: current and future challenges. Mohammadi D, Ghasemi M, Manouchehrian N, Zafarmand M, Akbari M, Boroumand AB. Mohammadi D, et al. Front Pharmacol. 2024 Nov 6;15:1434181. doi: 10.3389/fphar.2024.1434181. eCollection 2024. Front Pharmacol. 2024. PMID: 39568586 Free PMC article. Review.
  • Early outcomes of radical surgery in non-small-cell lung cancer patients with and without COVID-19 history: a multi-center real-world study. Pan H, Chen H, Li W, Tian Y, Ge Z, Kong W, Gu Z, Zou N, Zhu H, Zhang J, Tao Y, Ning J, Huang J, Yin H, Zhang M, Zhou C, Wang H, Xu G, Luo Q. Pan H, et al. Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241298794. doi: 10.1177/17534666241298794. Ther Adv Respir Dis. 2024. PMID: 39562312 Free PMC article.
  • Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity. D'Souza M, Keeshan A, Gravel CA, Langlois MA, Cooper CL. D'Souza M, et al. NPJ Vaccines. 2024 Nov 18;9(1):226. doi: 10.1038/s41541-024-01022-8. NPJ Vaccines. 2024. PMID: 39557875 Free PMC article.
  • Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning. Zhu L, Yao Y. Zhu L, et al. Front Immunol. 2024 Nov 1;15:1445618. doi: 10.3389/fimmu.2024.1445618. eCollection 2024. Front Immunol. 2024. PMID: 39555074 Free PMC article.
See all "Cited by" articles

References

    1. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192. - PMC - PubMed
    1. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395:689–697. - PMC - PubMed
    1. Hui DS, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China. Intl. J. Infect. Dis. 2020;91:264–266. - PMC - PubMed
    1. Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med. 2020;9:575. - PMC - PubMed
    1. Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J. Infect. 2020;80:373–377. - PMC - PubMed
Show all 166 references

Publication types

  • Research Support, Non-U.S. Gov't Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Review Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

MeSH terms

  • Age Factors Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Animals Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • COVID-19 / epidemiology* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • COVID-19 / pathology* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • COVID-19 / virology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Coronavirus / classification Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Coronavirus / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Humans Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Phylogeny Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • SARS-CoV-2 / classification Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • SARS-CoV-2 / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • SARS-CoV-2 / physiology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Zoonoses Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

Related information

  • Cited in Books
  • MedGen

LinkOut - more resources

  • Full Text Sources

    • Europe PubMed Central
    • Nature Publishing Group
    • PubMed Central

  • Other Literature Sources

    • The Lens - Patent Citations Database

  • Medical

    • MedlinePlus Health Information

  • Miscellaneous

    • NCI CPTAC Assay Portal
Full text links [x] full text provider logo Nature Publishing Group Free PMC article [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To
  • Clipboard
  • Email
  • Save
  • My Bibliography
  • Collections
  • Citation Manager
[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Từ khóa » Hu Et Al. 2020